MedTrace Logo

Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma

NCT04892810 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-05-19

No results posted yet for this study

Summary

This cohort study compares immune response induced in two groups of small HCC patients treated by ablation (group1 RFA, group 2 MWA). Patients will benefit for tumoral and non tumoral biopsies prior to treatment and stepped peripheral blood samples juste before ablation and during the first month after.

Conditions

Interventions

PROCEDURE

Percutaneous ablation

Hepatic Percutaneous Ablation with radiofrequency or microwave

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-31
Primary Completion
2022-06-30
Completion
2022-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04892810 on ClinicalTrials.gov